Agios Pharmaceuticals Inc. AGIO
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Agios Pharmaceuticals Inc. is a biopharmaceutical company specializing in cellular metabolism to develop differentiated medicines for rare diseases, with a particular emphasis on classical hematology. The company focuses on creating potentially transformative small-molecule therapies targeting unmet medical needs in he…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees539
TickerAGIO
Statistics
Market Cap$1.96B
Revenue (TTM)$54.0M
Net Income-$412.8M
Net Margin-764.0%
EPS$-7.12
P/E3.82
P/S25.86
P/B1.54
EV/EBITDA-2.16
ROE-32.8%
Dividend Yield—
Price$33.06
Data: Twelve Data · Revenue = mcap / P/S